- Report
- May 2022
- 100 Pages
Global
From €1494EUR$1,700USD£1,292GBP
- Report
- August 2024
- 243 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- February 2022
- 232 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- July 2024
- 293 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- July 2024
- 154 Pages
Global
From €3384EUR$3,850USD£2,927GBP
- Report
- September 2023
- 234 Pages
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- January 2024
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- December 2023
- 217 Pages
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- June 2023
- 235 Pages
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- June 2023
- 200 Pages
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- April 2022
- 230 Pages
Global
From €4263EUR$4,850USD£3,687GBP
- Report
- April 2022
- 120 Pages
Global
From €3384EUR$3,850USD£2,927GBP
- Report
- April 2022
- 250 Pages
Global
From €6021EUR$6,850USD£5,208GBP
- Report
- January 2022
- 100 Pages
Global
€3384EUR$3,850USD£2,927GBP
- Report
- December 2021
- 170 Pages
Global
€3384EUR$3,850USD£2,927GBP
- Report
- September 2021
- 100 Pages
Global
€3384EUR$3,850USD£2,927GBP
- Report
- November 2022
- 221 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- December 2023
- 164 Pages
Global
From €2066EUR$2,350USD£1,787GBP
- Report
- January 2023
- 127 Pages
Global
From €1978EUR$2,250USD£1,711GBP
- Report
- June 2024
- 185 Pages
Global
From €4878EUR$5,550USD£4,220GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more